Ranbaxy begins US generic Lipitor shipments from new Indian site
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has commenced supplies of its generic version of Pfizer's cholesterol lowering drug, Lipitor (atorvastatin), to the US from an Indian site in Mohali. Exports from this new facility come more than three years after the US FDA had in September 2008 issued an import alert for 30 of Ranbaxy's products, citing good manufacturing practice deviations at the firm's Paonta Sahib and Dewas plants in India.